Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Axitinib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR known ✓ | P35968 | 19/20 | 0.88 |
| ▸ | FLT1 known ✓ | P17948 | 3/20 | 0.88 |
| ▸ | FLT4 known ✓ | P35916 | 3/20 | 0.88 |
| ▸ | FGFR1 | P11362 | 7/20 | 0.88 |
| ▸ | LCK | P06239 | 3/20 | 0.88 |
| ▸ | PLK4 | O00444 | 2/20 | 0.88 |
| ▸ | AURKA | O14965 | 2/20 | 0.88 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.88 |
| ▸ | PAK4 | O96013 | 2/20 | 0.88 |
| ▸ | ABL1 | P00519 | 2/20 | 0.88 |
| ▸ | CSF1R | P07333 | 2/20 | 0.88 |
| ▸ | RET | P07949 | 2/20 | 0.88 |
| ▸ | MET | P08581 | 2/20 | 0.88 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.88 |
| ▸ | KIT | P10721 | 2/20 | 0.88 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.88 |
| ▸ | FGFR3 | P22607 | 2/20 | 0.88 |
| ▸ | TYK2 | P29597 | 2/20 | 0.88 |
| ▸ | AXL | P30530 | 2/20 | 0.88 |
| ▸ | BLK | P51451 | 2/20 | 0.88 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Axitinib SCHEMBL29459456 | 1.00 | KDR (0.88) | KDRFGFR1FLT1FLT4LCK | |
| Axitinib SCHEMBL2826667 | 0.94 | KDR (1.00) | KDRFGFR1FLT1FLT4LCK | |
| Axitinib SCHEMBL29349703 | 0.94 | KDR (1.00) | KDRFGFR1FLT1FLT4LCK | |
| Axitinib SCHEMBL29387511 | 0.94 | KDR (1.00) | KDRFGFR1FLT1FLT4LCK | |
| Axitinib SCHEMBL843204 | 0.94 | KDR (1.00) | KDRFGFR1FLT1FLT4LCK | |
| Axitinib SCHEMBL29384419 | 0.94 | KDR (1.00) | KDRFGFR1FLT1FLT4LCK | |
| Axitinib SCHEMBL172918 | 0.94 | KDR (1.00) | KDRFGFR1FLT1FLT4LCK | |
| Axitinib SCHEMBL5248175 | 0.93 | KDR (0.98) | KDRFGFR1FLT1FLT4LCK | |
| Axitinib SCHEMBL5248178 | 0.93 | KDR (0.98) | KDRFGFR1FLT1FLT4LCK | |
| SCHEMBL24503457 | 0.89 | KDR (0.84) | KDRFGFR1FLT1FLT4LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112442009-A | Deuterated compounds and their use for treating cancer | 润佳（苏州）医药科技有限公司 | 2021-03-05 | — | — | CN | claimed |
| CN-112442009-A | Deuterated compounds and their use for treating cancer | 润佳（苏州）医药科技有限公司 | 2021-03-05 | — | — | CN | disclosed |
| WO-2021037198-A1 | DEUTERATED COMPOUND AND USE THEREOF IN CANCER TREATMENT | 润佳（苏州）医药科技有限公司 | 2021-03-04 | — | — | WO | disclosed |